Neurosterix
PrivateLast Round
Series A
Apr 3, 2024
Est. Valuation
$98M
Total Funding Raised
$65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurosterix is a biopharmaceutical company that develops allosteric modulator therapeutics for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosterix Comparables
Compare Neurosterix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Addex Therapeutics | 81% | |
| Neumora | 80% | |
| Noema Pharma | 75% |
Neurosterix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 3, 2024 |
Neurosterix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| Xontogeny | Series A |
| Acorn Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 43% MoM, reaching 1K.
- Jul 25, 2026
Monthly visitors increased 702% MoM.
Recent news
Latest coverage and updates
- is_developingSep 27, 2026
Neurosterix is developing NTX-253 on Sep 28th '26.
Neurosterix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurosterix's valuation, stock price, and market status.
Is Neurosterix a public or private company?
Neurosterix is a private company.
What is the current stock price of Neurosterix?
Neurosterix is a private company with no public stock price. No recent secondary market data is available.
How much is Neurosterix worth (valuation)?
Neurosterix's valuation is estimated at $98.0M based on funding round data.
Can I buy Neurosterix stock?
Neurosterix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurosterix's last funding round?
Neurosterix's most recent funding round was Series A on April 2, 2024.
Who are the main investors in Neurosterix?
Key investors in Neurosterix include Perceptive Advisors, Xontogeny.
Will Neurosterix IPO soon?
No public IPO plans have been announced for Neurosterix.
How can I track Neurosterix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurosterix's secondary market activity and sign up for updates.